GetPortalImpactFactorByIdResp(projectId=1, id=7f1112414, cover=https://img.medsci.cn/images/journal/cover/2021/YSJ_202109271315183140.jpg, fullname=INFLAMMOPHARMACOLOGY, abbr=INFLAMMOPHARMACOLOGY, pyear=暂无数据, frequence=Quarterly, articleNumbers=793, citedSelf2015=7.0, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均8月, reviewFee=null, pageFee=null, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=0925-4692, greenSci=https://www.greensci.net/search?kw=0925-4692, scijournal=https://www.scijournal.org/impact-factor-of-INFLAMMOPHARMACOLOGY.shtml, medsciHotlightString=null, medsciHotlightRealtime=4.816, medsciHotlight=3.223, medsciHotlight5year=3.57927, citescore=8.0, hIndex=50, impactFactor=5.8, orgnization=Birkhauser Verlag Basel, orgnizationUrl=null, country=Switzerland, countryCn=瑞典, isOa=0, isOaString=否, sciScie=Science Citation Index Expanded|BIOSIS Previews, bigclassCas=医学 3区, smallclassCas=医学 3 区, website=https://www.springer.com/biomed/pharmacology+%26+toxicology/journal/10787, websiteHits=3954, guideForAuthor=null, guideForAuthorHits=12, submitWebsite=https://www.editorialmanager.com/iphm/default.aspx, submitWebsiteHits=2056, content=null, totalCites=4600, brief=INFLAMMOPHARMACOLOGY杂志医学行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=黑红, medsciComment=INFLAMMOPHARMACOLOGY在该细分领域可能是一流杂志，可能是创刊时间短或不是热门学科，整体来说，国内学者关注度仍然不够。对于投稿而言，建议多向"&abbr&"投稿，当然期刊也应该加强品牌宣传。, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='//m.capotfarm.com/sci/submit.do?id=7f1112414'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=9250, tagName=内皮细胞, createdHits=1), ImpactFactorTagDto(id=65723, tagName=亚麻酸, createdHits=1), ImpactFactorTagDto(id=27394, tagName=药理学, createdHits=1), ImpactFactorTagDto(id=4317, tagName=牙周炎, createdHits=1), ImpactFactorTagDto(id=4557, tagName=骨代谢, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2017, citescore=3.05), GetImpactFactorCiteScoreListResponse(year=2018, citescore=3.45), GetImpactFactorCiteScoreListResponse(year=2019, citescore=4.4), GetImpactFactorCiteScoreListResponse(year=2020, citescore=6.1), GetImpactFactorCiteScoreListResponse(year=2023, citescore=8.0)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=4.313), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=3.744), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=5.344), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=5.373), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=4.816)], citeScoreGradeList=[GetImpactFactorCiteScoreGradeResponse(smallClass=Medicine - Pharmacology (medical) , rank=39/232), GetImpactFactorCiteScoreGradeResponse(smallClass=Pharmacology, Toxicology and Pharmaceutics - Pharmacology , rank=66/300), GetImpactFactorCiteScoreGradeResponse(smallClass=Immunology and Microbiology - Immunology , rank=66/198)], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0925-4692[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=INFLAMMOPHARMACOLOGY[ta], article_number=193, article_number_cn=29, earlyWarning=null, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)